A Quick Look at Today's Ratings for Natera(NTRA.US), With a Forecast Between $200 to $251
Natera (NTRA) Receives a Buy From Piper Sandler
Natera Is Maintained at Overweight by Barclays
Natera Analyst Ratings
Barclays Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $190
Craig-Hallum Maintains Natera(NTRA.US) With Buy Rating
Craig-Hallum Maintains Natera(NTRA.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: CVRx (CVRX), Envista Holdings (NVST) and Natera (NTRA)
Natera Is Maintained at Overweight by Barclays
Natera Analyst Ratings
Barclays Maintains Natera(NTRA.US) With Buy Rating, Cuts Target Price to $160
Barclays Sticks to Their Buy Rating for Natera (NTRA)
RBC Capital Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $251
RBC Capital Sticks to Its Buy Rating for Natera (NTRA)
BTIG Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $190
Natera (NTRA) Receives a Buy From BTIG
Natera Analyst Ratings
RBC Capital Initiates Exact Sciences With Sector Perform, Natera With Outperform
RBC Initiates Natera at Outperform With $251 Price Target
RBC Capital Initiates Natera(NTRA.US) With Buy Rating, Announces Target Price $251